Skip to search formSkip to main contentSkip to account menu

FOLH1 gene

Known as: FOLH, GLUTAMATE CARBOXYPEPTIDASE II, folate hydrolase (prostate-specific membrane antigen) 1 
This gene plays a role in folate metabolism. It is also involved in neuronal transmission.
National Institutes of Health

Related topics

Related topics

7 relations

Narrower (1)

FOLH1 wt Allele
HydrolysisMolecular TransportNAALADL1 geneSynaptic Transmission

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PREVALENCE OF GLUTAMATE CARBOXYPEPTIDASE II C1561T, REDUCED FOLATE CARRIER 1 A80G, AND METHIONINE SYNTHASE A2756G GENE POLYMORPHISMS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AMONG SOUTH INDIANS
Objective: Glutamate carboxypeptidase II (GCPII), reduced folate carrier 1 (RFC1), and methionine synthase (MTR) genes involved… 
2019
2019
СОСТАВ ЖИРНЫХ КИСЛОТ ЛИПИДОВ СЫВОРОТКИ КРОВИ У ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ 1 ТИПА В СТАДИЮ ДЕКОМПЕНСАЦИИ В ЗАВИСИМОСТИ ОТ ТЯЖЕСТИ ДИАБЕТИЧЕСКОГО КЕТОАЦИДОЗА
Summary. In diabetic ketoacidosis, significant metabolic disorders develop in all organs and tissues, including the myocardium… 
2017
2017
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
CEQUEL (Comparative Evaluation of QUEtiapine plus Lamotrigine combination versus quetiapine monotherapy [and folic acid versus… 
2016
2016
Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach.
Prostate cancer (PCa) is the most frequently diagnosed cancer and the second most common cause of cancer related mortality in… 
2015
2015
Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer wi
  • 2015
  • Corpus ID: 11394170
In prostate cancer (PCa) and biochemical failure following therapy, current imaging techniques have a low detection rate at PSA… 
2012
2012
Evaluation of genetic heterogeneity in glutamate carboxypeptidase II (H475Y) and reduced folate carrier (SLC19A1) gene variants increased risk factor for the development of neural tube defects in…
In humans, neural tube failure to close during the 4th week of gestation leads to the development of severe congenital… 
2012
2012
Glutamate carboxypeptidase II (GCPII) genetic variants as determinants of hyperhomocysteinemia: implications in stroke susceptibility.
The rationale of this case-control study is to ascertain whether glutamate carboxypeptidase II (GCPII) variants serve as… 
2009
2009
Abstract #724: A phase 1 clinical trial of immune response and safety of an active immunotherapy regimen co-targeting PRAME and PSMA antigens in subjects with advanced solid malignancies
Background:This clinical trial is testing an investigational immunotherapeutic 3-component regimen encompassing a recombinant… 
2000
2000
Characterization of Prostate-Specific Membrane Antigen (PSMA) for Use in Therapeutic and Diagnostic Strategies against Prostate Cancer
Abstract : Prostate-Specific Membrane Antigen (PSMA) appears to be an ideal prostate cancer marker and potential therapeutic… 
1999
1999
Prostate-specific Membrane Antigen Levels in Sera from Healthy Men and Patients with Benign Prostate Hyperplasia or Prostate Cancer 1
Prostate-specific membrane antigen (PSMA) serum levels have been proposed to be of prognostic significance in patients with…